PD-1 inhibitor combined with TPF induction chemotherapy in locally advanced nasopharyngeal carcinoma: a retrospective study of efficacy and safety
The induction therapy of PD-1 inhibitor combined with TPF showed high CR and ORR rates in LA-NPC, and the safety was acceptable.
Authors
- Yousheng Meng
- Mingqing Dong (ORCID: https://orcid.org/0000-0001-9720-535X)
- Ping Zhang (ORCID: https://orcid.org/0000-0001-6214-557X)
- Weiwei Zhang (ORCID: https://orcid.org/0000-0002-5678-2051)
- Lang He (ORCID: https://orcid.org/0009-0000-7651-1147)
- Xianghua Zeng (ORCID: https://orcid.org/0009-0003-2588-9248)
- D. Tian (ORCID: https://orcid.org/0009-0008-3534-9938)
Institutions
- Wenzhou Medical University (CN)
- First Affiliated Hospital of Wenzhou Medical University (CN)
- Chengdu Fifth People's Hospital (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-09-16
- DOI
- https://doi.org/10.3389/fimmu.2025.1654616
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Chengdu University of Traditional Chinese Medicine
- Chengdu University